{"transactions":[{"id":1159590,"issuer":{"id":6814,"kind":"organization","name":"Mediaco Holding Inc."},"owners":[{"id":80154,"kind":"organization","name":"HPS Group GP, LLC","position":1,"cik":"0002019987","reported_name":"HPS Group GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":80155,"kind":"person","name":"Kapnick Scott","position":2,"cik":"0001709654","reported_name":"Kapnick Scott","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":80156,"kind":"organization","name":"SLF LBI Aggregator, LLC","position":3,"cik":"0002020124","reported_name":"SLF LBI Aggregator, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Option","published_at":"2025-05-05T18:12:12.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":false,"shares":7051538,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On April 17, 2024, the Issuer and certain subsidiaries entered into an option agreement with certain subsidiaries of SLF LBI Aggregator, LLC (\"Aggregator\"), including Estrella Media, Inc. (\"Estrella Media\"), pursuant to which, among other things, Estrella Media was granted the right to put the equity of certain subsidiaries of Estrella Media to a subsidiary of the Issuer in exchange for 7,051,538 shares of Class A Common Stock from and after October 17, 2024 until April 17, 2031, subject to certain extensions (the \"Option Transaction\"). On May 1, 2025, the parties consummated the Option Transaction and, pursuant to Estella Media's designation right, Aggregator received the 7,051,538 shares of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 17, 2024, the Issuer and certain subsidiaries entered into an option agreement with certain subsidiaries of SLF LBI Aggregator, LLC (\"Aggregator\"), including Estrella Media, Inc. (\"Estrella Media\"), pursuant to which, among other things, Estrella Media was granted the right to put the equity of certain subsidiaries of Estrella Media to a subsidiary of the Issuer in exchange for 7,051,538 shares of Class A Common Stock from and after October 17, 2024 until April 17, 2031, subject to certain extensions (the \"Option Transaction\"). On May 1, 2025, the parties consummated the Option Transaction and, pursuant to Estella Media's designation right, Aggregator received the 7,051,538 shares of Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 17, 2024, the Issuer and certain subsidiaries entered into an option agreement with certain subsidiaries of SLF LBI Aggregator, LLC (\"Aggregator\"), including Estrella Media, Inc. (\"Estrella Media\"), pursuant to which, among other things, Estrella Media was granted the right to put the equity of certain subsidiaries of Estrella Media to a subsidiary of the Issuer in exchange for 7,051,538 shares of Class A Common Stock from and after October 17, 2024 until April 17, 2031, subject to certain extensions (the \"Option Transaction\"). On May 1, 2025, the parties consummated the Option Transaction and, pursuant to Estella Media's designation right, Aggregator received the 7,051,538 shares of Class A Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On April 17, 2024, the Issuer and certain subsidiaries entered into an option agreement with certain subsidiaries of SLF LBI Aggregator, LLC (\"Aggregator\"), including Estrella Media, Inc. (\"Estrella Media\"), pursuant to which, among other things, Estrella Media was granted the right to put the equity of certain subsidiaries of Estrella Media to a subsidiary of the Issuer in exchange for 7,051,538 shares of Class A Common Stock from and after October 17, 2024 until April 17, 2031, subject to certain extensions (the \"Option Transaction\"). On May 1, 2025, the parties consummated the Option Transaction and, pursuant to Estella Media's designation right, Aggregator received the 7,051,538 shares of Class A Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"HPS Group GP, LLC (\"HPS Group\") is the non-member manager of Aggregator. Scott Kapnick is the sole member of HPS Group."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"On March 19, 2025, Estrella Media filed an Initial Statement of Beneficial Ownership to add Estrella Media as a reporting person with respect to the Put Right. This Form 4 reflects withdrawal of Estrella Media as a reporting person."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7051538},"source":{"system":"sec-edgar","filing":"0000950142-25-001254","document":"es250623799_4-mdia.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2020124/000095014225001254/es250623799_4-mdia.xml","form_type":"4"}},{"id":1159589,"issuer":{"id":6814,"kind":"organization","name":"Mediaco Holding Inc."},"owners":[{"id":80154,"kind":"organization","name":"HPS Group GP, LLC","position":1,"cik":"0002019987","reported_name":"HPS Group GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":80155,"kind":"person","name":"Kapnick Scott","position":2,"cik":"0001709654","reported_name":"Kapnick Scott","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":80156,"kind":"organization","name":"SLF LBI Aggregator, LLC","position":3,"cik":"0002020124","reported_name":"SLF LBI Aggregator, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-05-05T18:12:12.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":true,"shares":7051538,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 17, 2024, the Issuer and certain subsidiaries entered into an option agreement with certain subsidiaries of SLF LBI Aggregator, LLC (\"Aggregator\"), including Estrella Media, Inc. (\"Estrella Media\"), pursuant to which, among other things, Estrella Media was granted the right to put the equity of certain subsidiaries of Estrella Media to a subsidiary of the Issuer in exchange for 7,051,538 shares of Class A Common Stock from and after October 17, 2024 until April 17, 2031, subject to certain extensions (the \"Option Transaction\"). On May 1, 2025, the parties consummated the Option Transaction and, pursuant to Estella Media's designation right, Aggregator received the 7,051,538 shares of Class A Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"HPS Group GP, LLC (\"HPS Group\") is the non-member manager of Aggregator. Scott Kapnick is the sole member of HPS Group."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"On March 19, 2025, Estrella Media filed an Initial Statement of Beneficial Ownership to add Estrella Media as a reporting person with respect to the Put Right. This Form 4 reflects withdrawal of Estrella Media as a reporting person."}],"balance_after":7051538,"source":{"system":"sec-edgar","filing":"0000950142-25-001254","document":"es250623799_4-mdia.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020124/000095014225001254/es250623799_4-mdia.xml","form_type":"4"}},{"id":3844648,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":80155,"kind":"person","name":"Kapnick Scott","position":1,"cik":"0001709654","reported_name":"Kapnick Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-14T20:35:26.000Z","date":"2017-07-05","kind":"purchase","acquired":true,"shares":66666,"price":15,"value":999990.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The amount of securities previously reported as beneficially owned by the Reporting Person inadvertently aggregated shares that the Reporting Person indirectly beneficially owned with shares that the Reporting Person directly beneficially owned following the transaction reported on the original Form 4. The correct number of shares that the Reporting Person indirectly beneficially owned following this transaction was 66,666 shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly owned by Jake86 LLC, for which the Reporting Person serves as investment manager. The Reporting Person disclaims beneficial ownership of the shares held by Jake86 LLC, except to the extent of his indirect pecuniary interest therein."}],"balance_after":66666,"source":{"system":"sec-edgar","filing":"0000899243-18-022295","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924318022295/doc4a.xml","form_type":"4/A","original_submission_date":"2017-07-05"}},{"id":4250004,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":80155,"kind":"person","name":"Kapnick Scott","position":1,"cik":"0001709654","reported_name":"Kapnick Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-27T22:29:21.000Z","date":"2017-07-25","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on July 25, 2017. The shares underlying the option are scheduled to vest in equal annual installments over three years from July 25, 2017."}],"balance_after":20000,"derivative":{"exercise_price":13,"expiration_date":"2027-07-24","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-17-019212","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924317019212/doc4.xml","form_type":"4"}},{"id":4264079,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":80155,"kind":"person","name":"Kapnick Scott","position":1,"cik":"0001709654","reported_name":"Kapnick Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Preferred Stock","published_at":"2017-07-06T00:25:29.000Z","date":"2017-07-05","kind":"exercise","acquired":false,"shares":487776,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":49086},"source":{"system":"sec-edgar","filing":"0000899243-17-017894","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924317017894/doc4.xml","form_type":"4"}},{"id":4264078,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":80155,"kind":"person","name":"Kapnick Scott","position":1,"cik":"0001709654","reported_name":"Kapnick Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E-3 Preferred Stock","published_at":"2017-07-06T00:25:29.000Z","date":"2017-07-05","kind":"exercise","acquired":false,"shares":1266130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":127415},"source":{"system":"sec-edgar","filing":"0000899243-17-017894","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924317017894/doc4.xml","form_type":"4"}},{"id":4264077,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":80155,"kind":"person","name":"Kapnick Scott","position":1,"cik":"0001709654","reported_name":"Kapnick Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E-2 Preferred Stock","published_at":"2017-07-06T00:25:29.000Z","date":"2017-07-05","kind":"exercise","acquired":false,"shares":612002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":61588},"source":{"system":"sec-edgar","filing":"0000899243-17-017894","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924317017894/doc4.xml","form_type":"4"}},{"id":4264076,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":80155,"kind":"person","name":"Kapnick Scott","position":1,"cik":"0001709654","reported_name":"Kapnick Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D-1 Preferred Stock","published_at":"2017-07-06T00:25:29.000Z","date":"2017-07-05","kind":"exercise","acquired":false,"shares":363636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":36594},"source":{"system":"sec-edgar","filing":"0000899243-17-017894","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924317017894/doc4.xml","form_type":"4"}},{"id":4264075,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":80155,"kind":"person","name":"Kapnick Scott","position":1,"cik":"0001709654","reported_name":"Kapnick Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2017-07-06T00:25:29.000Z","date":"2017-07-05","kind":"exercise","acquired":false,"shares":106856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10753},"source":{"system":"sec-edgar","filing":"0000899243-17-017894","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924317017894/doc4.xml","form_type":"4"}},{"id":4264074,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":80155,"kind":"person","name":"Kapnick Scott","position":1,"cik":"0001709654","reported_name":"Kapnick Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-07-06T00:25:29.000Z","date":"2017-07-05","kind":"purchase","acquired":true,"shares":66666,"price":15,"value":999990.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly owned by Jake86 LLC, for which the Reporting Person serves as investment manager. The Reporting Person disclaims beneficial ownership of the shares held by Jake86 LLC, except to the extent of his indirect pecuniary interest therein."}],"balance_after":521049,"source":{"system":"sec-edgar","filing":"0000899243-17-017894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924317017894/doc4.xml","form_type":"4"}},{"id":4264073,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":80155,"kind":"person","name":"Kapnick Scott","position":1,"cik":"0001709654","reported_name":"Kapnick Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-07-06T00:25:29.000Z","date":"2017-07-05","kind":"purchase","acquired":true,"shares":159307,"price":15,"value":2389605.0,"ownership":{"direct":true},"balance_after":454383,"source":{"system":"sec-edgar","filing":"0000899243-17-017894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924317017894/doc4.xml","form_type":"4"}},{"id":4264072,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":80155,"kind":"person","name":"Kapnick Scott","position":1,"cik":"0001709654","reported_name":"Kapnick Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-07-06T00:25:29.000Z","date":"2017-07-05","kind":"exercise","acquired":true,"shares":285438,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series D-1, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."}],"balance_after":295076,"source":{"system":"sec-edgar","filing":"0000899243-17-017894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924317017894/doc4.xml","form_type":"4"}}]}